File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial

TitleEmpagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
Authors
Issue Date2022
Citation
Acta Diabetologica, 2022, v. 59, p. 575-578 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/312305

 

DC FieldValueLanguage
dc.contributor.authorRai, A-
dc.contributor.authorConnelly, KA-
dc.contributor.authorVerma, S-
dc.contributor.authorMazer, CD-
dc.contributor.authorTeoh, H-
dc.contributor.authorNg, MY-
dc.contributor.authorRoifman, I-
dc.contributor.authorQuan, A-
dc.contributor.authorPourafkari, M-
dc.contributor.authorJimenez-Juan, L-
dc.contributor.authorRamanan, V-
dc.contributor.authorGe, Y-
dc.contributor.authorDeva, DJ-
dc.contributor.authorYan, AT-
dc.date.accessioned2022-04-25T01:37:55Z-
dc.date.available2022-04-25T01:37:55Z-
dc.date.issued2022-
dc.identifier.citationActa Diabetologica, 2022, v. 59, p. 575-578-
dc.identifier.urihttp://hdl.handle.net/10722/312305-
dc.languageeng-
dc.relation.ispartofActa Diabetologica-
dc.titleEmpagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial-
dc.typeArticle-
dc.identifier.emailNg, MY: myng2@hku.hk-
dc.identifier.authorityNg, MY=rp01976-
dc.identifier.doi10.1007/s00592-021-01823-6-
dc.identifier.hkuros332736-
dc.identifier.volume59-
dc.identifier.spage575-
dc.identifier.epage578-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats